Stockreport

Evoke Pharma Granted 180-Day Extension by Nasdaq Regarding Minimum Bid Price

Evoke Pharma, Inc.  (EVOK) 
Last evoke pharma, inc. earnings: 11/7 08:30 am Check Earnings Report
US:NASDAQ Investor Relations: evokepharmainc.gcs-web.com/investor-overview
PDF SOLANA BEACH, Calif., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestina [Read more]